Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer.
暂无分享，去创建一个
F. Ognibene | D. Venzon | K. Cowan | F. Balis | J. O’Shaughnessy | A. Denicoff | C. Chow | S. Berg | D. Poplack | J. Fisherman | M. Noone | M. McCabe | B. Goldspiel | M. Noone | McCabe Ms | Fisherman Js